![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
Michael Baker Maintained (UNH) at Strong Buy with Increased Target to $304 on, Sep 24th, 2018
Michael Baker of Raymond James, Maintained "UnitedHealth Group Incorporated" (UNH) at Strong Buy with Increased Target from $285 to $304 on, Sep 24th, 2018.
Michael has made no other calls on UNH in the last 4 months.
There are 4 other peers that have a rating on UNH. Out of the 4 peers that are also analyzing UNH, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ralph Giacobbe of "Citigroup" Downgraded from Strong Buy to Hold on, Monday, September 10th, 2018
These are the ratings of the 3 analyists that currently disagree with Michael
- Andrew Schenker of "Morgan Stanley" Maintained at Buy with Increased Target to $305 on, Wednesday, September 5th, 2018
- Anton Hie of "RBC Capital" Maintained at Buy with Increased Target to $284 on, Wednesday, July 18th, 2018
- Matt Borsch of "BMO Capital" Maintained at Buy with Increased Target to $300 on, Thursday, June 21st, 2018